Pharmaceuticals and personal care products in the environment: What are the big questions?
- Autores
- Boxall, Alistair B. A.; Rudd, Murray A.; Brooks, Bryan W.; Caldwell, Daniel J.; Choi, Kyungho; Hickmann, Silke; Innes, Elizabeth; Ostapyk, Kim; Staveley, Jane P.; Verslycke, Tim; Ankley, Gerald T.; Beazley, Karen F.; Belanger, Scott E.; Berninger, Jason P.; Carriquiriborde, Pedro; Coors, Anja; DeLeo, Paul C.; Dyer, Scott D.; Ericson, Jon F.; Gagné, François; Giesy, John P.; Gouin, Todd; Hallstrom, Lars; Karlsson, Maja V.; Joakim Larsson, D.G.; Lazorchak, James M.; Mastrocco, Frank; McLaughlin, Alison; McMaster, Mark E.; Meyerhoff, Roger D.; Moore, Roberta; Parrott, Joanne L.; Snape, Jason R.; Murray-Smith, Richard; Servos, Mark R.; Sibley, Paul K.; Straub, Jürg Oliver; Szabo, Nora D.; Topp, Edward; Tetreault, Gerald R.; Trudeau, Vance L.; Van Der Kraak, Glen
- Año de publicación
- 2012
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Background: Over the past 10-15 years, a substantial amount of work has been done by the scientific, regulatory, and business communities to elucidate the effects and risks of pharmaceuticals and personal care products (PPCPs) in the environment. Objective: This review was undertaken to identify key outstanding issues regarding the effects of PPCPs on human and ecological health in order to ensure that future resources will be focused on the most important areas. Data sources: To better understand and manage the risks of PPCPs in the environment, we used the "key question" approach to identify the principle issues that need to be addressed. Initially, questions were solicited from academic, government, and business communities around the world. A list of 101 questions was then discussed at an international expert workshop, and a top-20 list was developed. Following the workshop, workshop attendees ranked the 20 questions by importance. Data synthesis: The top 20 priority questions fell into seven categories: a) prioritization of substances for assessment, b) pathways of exposure, c) bioavailability and uptake, d) effects characterization, e) risk and relative risk, f) antibiotic resistance, and g) risk management. Conclusions: A large body of information is now available on PPCPs in the environment. This exercise prioritized the most critical questions to aid in development of future research programs on the topic.
Fil: Boxall, Alistair B. A.. University of York; Reino Unido
Fil: Rudd, Murray A.. University of York; Reino Unido
Fil: Brooks, Bryan W.. Baylor University; Estados Unidos
Fil: Caldwell, Daniel J.. Johnson & Johnson; Estados Unidos
Fil: Choi, Kyungho. Seoul National University; Corea del Sur
Fil: Hickmann, Silke. Umweltbundesamt; Alemania
Fil: Innes, Elizabeth. Health Canada; Canadá
Fil: Ostapyk, Kim. Health Canada; Canadá
Fil: Staveley, Jane P.. Exponent; Estados Unidos
Fil: Verslycke, Tim. Gradient; Estados Unidos
Fil: Ankley, Gerald T.. United States Environmental Protection Agency; Estados Unidos
Fil: Beazley, Karen F.. Dalhousie University Halifax; Canadá
Fil: Belanger, Scott E.. Procter And Gamble; Estados Unidos
Fil: Berninger, Jason P.. Baylor University; Estados Unidos
Fil: Carriquiriborde, Pedro. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata; Argentina. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Departamento de Química. Centro de Investigaciones del Medio Ambiente; Argentina
Fil: Coors, Anja. Ect Oekotoxikologie Gmbh; Alemania
Fil: DeLeo, Paul C.. American Cleaning Institute; Estados Unidos
Fil: Dyer, Scott D.. Procter And Gamble; Estados Unidos
Fil: Ericson, Jon F.. Pfizer Inc.; Estados Unidos
Fil: Gagné, François. Environment Canada; Canadá
Fil: Giesy, John P.. University of Saskatchewan; Canadá
Fil: Gouin, Todd. Unilever; Reino Unido
Fil: Hallstrom, Lars. University of Alberta; Canadá
Fil: Karlsson, Maja V.. University of York; Reino Unido
Fil: Joakim Larsson, D.G.. University of Göteborg; Alemania
Fil: Lazorchak, James M.. United States Environmental Protection Agency; Estados Unidos
Fil: Mastrocco, Frank. Pfizer Inc.; Estados Unidos
Fil: McLaughlin, Alison. Health Canada; Canadá
Fil: McMaster, Mark E.. Environment Canada; Canadá
Fil: Meyerhoff, Roger D.. Eli Lilly And Company; Estados Unidos
Fil: Moore, Roberta. Health Canada; Canadá
Fil: Parrott, Joanne L.. Environment Canada; Canadá
Fil: Snape, Jason R.. AstraZeneca UK Ltd.; Reino Unido
Fil: Murray-Smith, Richard. AstraZeneca UK Ltd.; Reino Unido
Fil: Servos, Mark R.. University of Waterloo; Canadá
Fil: Sibley, Paul K.. University of Guelph; Canadá
Fil: Straub, Jürg Oliver. F. Hoffmann-La Roche Ltd.; Suiza
Fil: Szabo, Nora D.. University of Ottawa; Canadá
Fil: Topp, Edward. Agriculture Et Agroalimentaire Canada; Canadá
Fil: Tetreault, Gerald R.. University of Waterloo; Canadá
Fil: Trudeau, Vance L.. University of Ottawa; Canadá
Fil: Van Der Kraak, Glen. University of Guelph; Canadá - Materia
-
ANTIBIOTIC RESISTANCE
ECOTOXICITY
EXPOSURE ASSESSMENT
HEALTH EFFECTS
PERSONAL CARE PRODUCTS
PHARMACEUTICALS
PRIORITIZATION
RISK ASSESSMENT
RISK MANAGEMENT - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
.jpg)
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/81809
Ver los metadatos del registro completo
| id |
CONICETDig_15e7d002196b3e628705dbf924dc322a |
|---|---|
| oai_identifier_str |
oai:ri.conicet.gov.ar:11336/81809 |
| network_acronym_str |
CONICETDig |
| repository_id_str |
3498 |
| network_name_str |
CONICET Digital (CONICET) |
| spelling |
Pharmaceuticals and personal care products in the environment: What are the big questions?Boxall, Alistair B. A.Rudd, Murray A.Brooks, Bryan W.Caldwell, Daniel J.Choi, KyunghoHickmann, SilkeInnes, ElizabethOstapyk, KimStaveley, Jane P.Verslycke, TimAnkley, Gerald T.Beazley, Karen F.Belanger, Scott E.Berninger, Jason P.Carriquiriborde, PedroCoors, AnjaDeLeo, Paul C.Dyer, Scott D.Ericson, Jon F.Gagné, FrançoisGiesy, John P.Gouin, ToddHallstrom, LarsKarlsson, Maja V.Joakim Larsson, D.G.Lazorchak, James M.Mastrocco, FrankMcLaughlin, AlisonMcMaster, Mark E.Meyerhoff, Roger D.Moore, RobertaParrott, Joanne L.Snape, Jason R.Murray-Smith, RichardServos, Mark R.Sibley, Paul K.Straub, Jürg OliverSzabo, Nora D.Topp, EdwardTetreault, Gerald R.Trudeau, Vance L.Van Der Kraak, GlenANTIBIOTIC RESISTANCEECOTOXICITYEXPOSURE ASSESSMENTHEALTH EFFECTSPERSONAL CARE PRODUCTSPHARMACEUTICALSPRIORITIZATIONRISK ASSESSMENTRISK MANAGEMENThttps://purl.org/becyt/ford/1.5https://purl.org/becyt/ford/1Background: Over the past 10-15 years, a substantial amount of work has been done by the scientific, regulatory, and business communities to elucidate the effects and risks of pharmaceuticals and personal care products (PPCPs) in the environment. Objective: This review was undertaken to identify key outstanding issues regarding the effects of PPCPs on human and ecological health in order to ensure that future resources will be focused on the most important areas. Data sources: To better understand and manage the risks of PPCPs in the environment, we used the "key question" approach to identify the principle issues that need to be addressed. Initially, questions were solicited from academic, government, and business communities around the world. A list of 101 questions was then discussed at an international expert workshop, and a top-20 list was developed. Following the workshop, workshop attendees ranked the 20 questions by importance. Data synthesis: The top 20 priority questions fell into seven categories: a) prioritization of substances for assessment, b) pathways of exposure, c) bioavailability and uptake, d) effects characterization, e) risk and relative risk, f) antibiotic resistance, and g) risk management. Conclusions: A large body of information is now available on PPCPs in the environment. This exercise prioritized the most critical questions to aid in development of future research programs on the topic.Fil: Boxall, Alistair B. A.. University of York; Reino UnidoFil: Rudd, Murray A.. University of York; Reino UnidoFil: Brooks, Bryan W.. Baylor University; Estados UnidosFil: Caldwell, Daniel J.. Johnson & Johnson; Estados UnidosFil: Choi, Kyungho. Seoul National University; Corea del SurFil: Hickmann, Silke. Umweltbundesamt; AlemaniaFil: Innes, Elizabeth. Health Canada; CanadáFil: Ostapyk, Kim. Health Canada; CanadáFil: Staveley, Jane P.. Exponent; Estados UnidosFil: Verslycke, Tim. Gradient; Estados UnidosFil: Ankley, Gerald T.. United States Environmental Protection Agency; Estados UnidosFil: Beazley, Karen F.. Dalhousie University Halifax; CanadáFil: Belanger, Scott E.. Procter And Gamble; Estados UnidosFil: Berninger, Jason P.. Baylor University; Estados UnidosFil: Carriquiriborde, Pedro. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata; Argentina. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Departamento de Química. Centro de Investigaciones del Medio Ambiente; ArgentinaFil: Coors, Anja. Ect Oekotoxikologie Gmbh; AlemaniaFil: DeLeo, Paul C.. American Cleaning Institute; Estados UnidosFil: Dyer, Scott D.. Procter And Gamble; Estados UnidosFil: Ericson, Jon F.. Pfizer Inc.; Estados UnidosFil: Gagné, François. Environment Canada; CanadáFil: Giesy, John P.. University of Saskatchewan; CanadáFil: Gouin, Todd. Unilever; Reino UnidoFil: Hallstrom, Lars. University of Alberta; CanadáFil: Karlsson, Maja V.. University of York; Reino UnidoFil: Joakim Larsson, D.G.. University of Göteborg; AlemaniaFil: Lazorchak, James M.. United States Environmental Protection Agency; Estados UnidosFil: Mastrocco, Frank. Pfizer Inc.; Estados UnidosFil: McLaughlin, Alison. Health Canada; CanadáFil: McMaster, Mark E.. Environment Canada; CanadáFil: Meyerhoff, Roger D.. Eli Lilly And Company; Estados UnidosFil: Moore, Roberta. Health Canada; CanadáFil: Parrott, Joanne L.. Environment Canada; CanadáFil: Snape, Jason R.. AstraZeneca UK Ltd.; Reino UnidoFil: Murray-Smith, Richard. AstraZeneca UK Ltd.; Reino UnidoFil: Servos, Mark R.. University of Waterloo; CanadáFil: Sibley, Paul K.. University of Guelph; CanadáFil: Straub, Jürg Oliver. F. Hoffmann-La Roche Ltd.; SuizaFil: Szabo, Nora D.. University of Ottawa; CanadáFil: Topp, Edward. Agriculture Et Agroalimentaire Canada; CanadáFil: Tetreault, Gerald R.. University of Waterloo; CanadáFil: Trudeau, Vance L.. University of Ottawa; CanadáFil: Van Der Kraak, Glen. University of Guelph; CanadáU.S. Department of Health and Human Sciences. Public Health and Science2012-05info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/81809Boxall, Alistair B. A.; Rudd, Murray A.; Brooks, Bryan W.; Caldwell, Daniel J.; Choi, Kyungho; et al.; Pharmaceuticals and personal care products in the environment: What are the big questions?; U.S. Department of Health and Human Sciences. Public Health and Science; Environmental Health Perspectives; 120; 9; 5-2012; 1221-12291552-99240091-6765CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1289/ehp.1104477info:eu-repo/semantics/altIdentifier/url/https://ehp.niehs.nih.gov/doi/10.1289/ehp.1104477info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-10-15T15:21:04Zoai:ri.conicet.gov.ar:11336/81809instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-10-15 15:21:04.244CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
| dc.title.none.fl_str_mv |
Pharmaceuticals and personal care products in the environment: What are the big questions? |
| title |
Pharmaceuticals and personal care products in the environment: What are the big questions? |
| spellingShingle |
Pharmaceuticals and personal care products in the environment: What are the big questions? Boxall, Alistair B. A. ANTIBIOTIC RESISTANCE ECOTOXICITY EXPOSURE ASSESSMENT HEALTH EFFECTS PERSONAL CARE PRODUCTS PHARMACEUTICALS PRIORITIZATION RISK ASSESSMENT RISK MANAGEMENT |
| title_short |
Pharmaceuticals and personal care products in the environment: What are the big questions? |
| title_full |
Pharmaceuticals and personal care products in the environment: What are the big questions? |
| title_fullStr |
Pharmaceuticals and personal care products in the environment: What are the big questions? |
| title_full_unstemmed |
Pharmaceuticals and personal care products in the environment: What are the big questions? |
| title_sort |
Pharmaceuticals and personal care products in the environment: What are the big questions? |
| dc.creator.none.fl_str_mv |
Boxall, Alistair B. A. Rudd, Murray A. Brooks, Bryan W. Caldwell, Daniel J. Choi, Kyungho Hickmann, Silke Innes, Elizabeth Ostapyk, Kim Staveley, Jane P. Verslycke, Tim Ankley, Gerald T. Beazley, Karen F. Belanger, Scott E. Berninger, Jason P. Carriquiriborde, Pedro Coors, Anja DeLeo, Paul C. Dyer, Scott D. Ericson, Jon F. Gagné, François Giesy, John P. Gouin, Todd Hallstrom, Lars Karlsson, Maja V. Joakim Larsson, D.G. Lazorchak, James M. Mastrocco, Frank McLaughlin, Alison McMaster, Mark E. Meyerhoff, Roger D. Moore, Roberta Parrott, Joanne L. Snape, Jason R. Murray-Smith, Richard Servos, Mark R. Sibley, Paul K. Straub, Jürg Oliver Szabo, Nora D. Topp, Edward Tetreault, Gerald R. Trudeau, Vance L. Van Der Kraak, Glen |
| author |
Boxall, Alistair B. A. |
| author_facet |
Boxall, Alistair B. A. Rudd, Murray A. Brooks, Bryan W. Caldwell, Daniel J. Choi, Kyungho Hickmann, Silke Innes, Elizabeth Ostapyk, Kim Staveley, Jane P. Verslycke, Tim Ankley, Gerald T. Beazley, Karen F. Belanger, Scott E. Berninger, Jason P. Carriquiriborde, Pedro Coors, Anja DeLeo, Paul C. Dyer, Scott D. Ericson, Jon F. Gagné, François Giesy, John P. Gouin, Todd Hallstrom, Lars Karlsson, Maja V. Joakim Larsson, D.G. Lazorchak, James M. Mastrocco, Frank McLaughlin, Alison McMaster, Mark E. Meyerhoff, Roger D. Moore, Roberta Parrott, Joanne L. Snape, Jason R. Murray-Smith, Richard Servos, Mark R. Sibley, Paul K. Straub, Jürg Oliver Szabo, Nora D. Topp, Edward Tetreault, Gerald R. Trudeau, Vance L. Van Der Kraak, Glen |
| author_role |
author |
| author2 |
Rudd, Murray A. Brooks, Bryan W. Caldwell, Daniel J. Choi, Kyungho Hickmann, Silke Innes, Elizabeth Ostapyk, Kim Staveley, Jane P. Verslycke, Tim Ankley, Gerald T. Beazley, Karen F. Belanger, Scott E. Berninger, Jason P. Carriquiriborde, Pedro Coors, Anja DeLeo, Paul C. Dyer, Scott D. Ericson, Jon F. Gagné, François Giesy, John P. Gouin, Todd Hallstrom, Lars Karlsson, Maja V. Joakim Larsson, D.G. Lazorchak, James M. Mastrocco, Frank McLaughlin, Alison McMaster, Mark E. Meyerhoff, Roger D. Moore, Roberta Parrott, Joanne L. Snape, Jason R. Murray-Smith, Richard Servos, Mark R. Sibley, Paul K. Straub, Jürg Oliver Szabo, Nora D. Topp, Edward Tetreault, Gerald R. Trudeau, Vance L. Van Der Kraak, Glen |
| author2_role |
author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author |
| dc.subject.none.fl_str_mv |
ANTIBIOTIC RESISTANCE ECOTOXICITY EXPOSURE ASSESSMENT HEALTH EFFECTS PERSONAL CARE PRODUCTS PHARMACEUTICALS PRIORITIZATION RISK ASSESSMENT RISK MANAGEMENT |
| topic |
ANTIBIOTIC RESISTANCE ECOTOXICITY EXPOSURE ASSESSMENT HEALTH EFFECTS PERSONAL CARE PRODUCTS PHARMACEUTICALS PRIORITIZATION RISK ASSESSMENT RISK MANAGEMENT |
| purl_subject.fl_str_mv |
https://purl.org/becyt/ford/1.5 https://purl.org/becyt/ford/1 |
| dc.description.none.fl_txt_mv |
Background: Over the past 10-15 years, a substantial amount of work has been done by the scientific, regulatory, and business communities to elucidate the effects and risks of pharmaceuticals and personal care products (PPCPs) in the environment. Objective: This review was undertaken to identify key outstanding issues regarding the effects of PPCPs on human and ecological health in order to ensure that future resources will be focused on the most important areas. Data sources: To better understand and manage the risks of PPCPs in the environment, we used the "key question" approach to identify the principle issues that need to be addressed. Initially, questions were solicited from academic, government, and business communities around the world. A list of 101 questions was then discussed at an international expert workshop, and a top-20 list was developed. Following the workshop, workshop attendees ranked the 20 questions by importance. Data synthesis: The top 20 priority questions fell into seven categories: a) prioritization of substances for assessment, b) pathways of exposure, c) bioavailability and uptake, d) effects characterization, e) risk and relative risk, f) antibiotic resistance, and g) risk management. Conclusions: A large body of information is now available on PPCPs in the environment. This exercise prioritized the most critical questions to aid in development of future research programs on the topic. Fil: Boxall, Alistair B. A.. University of York; Reino Unido Fil: Rudd, Murray A.. University of York; Reino Unido Fil: Brooks, Bryan W.. Baylor University; Estados Unidos Fil: Caldwell, Daniel J.. Johnson & Johnson; Estados Unidos Fil: Choi, Kyungho. Seoul National University; Corea del Sur Fil: Hickmann, Silke. Umweltbundesamt; Alemania Fil: Innes, Elizabeth. Health Canada; Canadá Fil: Ostapyk, Kim. Health Canada; Canadá Fil: Staveley, Jane P.. Exponent; Estados Unidos Fil: Verslycke, Tim. Gradient; Estados Unidos Fil: Ankley, Gerald T.. United States Environmental Protection Agency; Estados Unidos Fil: Beazley, Karen F.. Dalhousie University Halifax; Canadá Fil: Belanger, Scott E.. Procter And Gamble; Estados Unidos Fil: Berninger, Jason P.. Baylor University; Estados Unidos Fil: Carriquiriborde, Pedro. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata; Argentina. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Departamento de Química. Centro de Investigaciones del Medio Ambiente; Argentina Fil: Coors, Anja. Ect Oekotoxikologie Gmbh; Alemania Fil: DeLeo, Paul C.. American Cleaning Institute; Estados Unidos Fil: Dyer, Scott D.. Procter And Gamble; Estados Unidos Fil: Ericson, Jon F.. Pfizer Inc.; Estados Unidos Fil: Gagné, François. Environment Canada; Canadá Fil: Giesy, John P.. University of Saskatchewan; Canadá Fil: Gouin, Todd. Unilever; Reino Unido Fil: Hallstrom, Lars. University of Alberta; Canadá Fil: Karlsson, Maja V.. University of York; Reino Unido Fil: Joakim Larsson, D.G.. University of Göteborg; Alemania Fil: Lazorchak, James M.. United States Environmental Protection Agency; Estados Unidos Fil: Mastrocco, Frank. Pfizer Inc.; Estados Unidos Fil: McLaughlin, Alison. Health Canada; Canadá Fil: McMaster, Mark E.. Environment Canada; Canadá Fil: Meyerhoff, Roger D.. Eli Lilly And Company; Estados Unidos Fil: Moore, Roberta. Health Canada; Canadá Fil: Parrott, Joanne L.. Environment Canada; Canadá Fil: Snape, Jason R.. AstraZeneca UK Ltd.; Reino Unido Fil: Murray-Smith, Richard. AstraZeneca UK Ltd.; Reino Unido Fil: Servos, Mark R.. University of Waterloo; Canadá Fil: Sibley, Paul K.. University of Guelph; Canadá Fil: Straub, Jürg Oliver. F. Hoffmann-La Roche Ltd.; Suiza Fil: Szabo, Nora D.. University of Ottawa; Canadá Fil: Topp, Edward. Agriculture Et Agroalimentaire Canada; Canadá Fil: Tetreault, Gerald R.. University of Waterloo; Canadá Fil: Trudeau, Vance L.. University of Ottawa; Canadá Fil: Van Der Kraak, Glen. University of Guelph; Canadá |
| description |
Background: Over the past 10-15 years, a substantial amount of work has been done by the scientific, regulatory, and business communities to elucidate the effects and risks of pharmaceuticals and personal care products (PPCPs) in the environment. Objective: This review was undertaken to identify key outstanding issues regarding the effects of PPCPs on human and ecological health in order to ensure that future resources will be focused on the most important areas. Data sources: To better understand and manage the risks of PPCPs in the environment, we used the "key question" approach to identify the principle issues that need to be addressed. Initially, questions were solicited from academic, government, and business communities around the world. A list of 101 questions was then discussed at an international expert workshop, and a top-20 list was developed. Following the workshop, workshop attendees ranked the 20 questions by importance. Data synthesis: The top 20 priority questions fell into seven categories: a) prioritization of substances for assessment, b) pathways of exposure, c) bioavailability and uptake, d) effects characterization, e) risk and relative risk, f) antibiotic resistance, and g) risk management. Conclusions: A large body of information is now available on PPCPs in the environment. This exercise prioritized the most critical questions to aid in development of future research programs on the topic. |
| publishDate |
2012 |
| dc.date.none.fl_str_mv |
2012-05 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/81809 Boxall, Alistair B. A.; Rudd, Murray A.; Brooks, Bryan W.; Caldwell, Daniel J.; Choi, Kyungho; et al.; Pharmaceuticals and personal care products in the environment: What are the big questions?; U.S. Department of Health and Human Sciences. Public Health and Science; Environmental Health Perspectives; 120; 9; 5-2012; 1221-1229 1552-9924 0091-6765 CONICET Digital CONICET |
| url |
http://hdl.handle.net/11336/81809 |
| identifier_str_mv |
Boxall, Alistair B. A.; Rudd, Murray A.; Brooks, Bryan W.; Caldwell, Daniel J.; Choi, Kyungho; et al.; Pharmaceuticals and personal care products in the environment: What are the big questions?; U.S. Department of Health and Human Sciences. Public Health and Science; Environmental Health Perspectives; 120; 9; 5-2012; 1221-1229 1552-9924 0091-6765 CONICET Digital CONICET |
| dc.language.none.fl_str_mv |
eng |
| language |
eng |
| dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/doi/10.1289/ehp.1104477 info:eu-repo/semantics/altIdentifier/url/https://ehp.niehs.nih.gov/doi/10.1289/ehp.1104477 |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
| eu_rights_str_mv |
openAccess |
| rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
| dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf application/pdf |
| dc.publisher.none.fl_str_mv |
U.S. Department of Health and Human Sciences. Public Health and Science |
| publisher.none.fl_str_mv |
U.S. Department of Health and Human Sciences. Public Health and Science |
| dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
| reponame_str |
CONICET Digital (CONICET) |
| collection |
CONICET Digital (CONICET) |
| instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
| repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
| repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
| _version_ |
1846083359073107968 |
| score |
13.22299 |